Integral Diagnostics Ltd (IDX)

Currency in AUD
2.24
+0.01(+0.45%)
Closed·

IDX Financial Summary

Key Ratios

P/E Ratio59.2
Price/Book1.16
Debt / Equity88.22%
Return on Equity2.06%
Dividend Yield3.27%
EBITDA86.00M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2016
30/06
2017
30/06
2018
30/06
2019
30/06
2020
30/06
2021
30/06
2022
30/06
2023
30/06
2024
30/06
2025
30/06
* In Millions of AUD (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.04%
Dividend Yield
3.27%
Industry Median 3.48%
Annualized payout
0.07
Paid annually
5-Years Growth
-5.13%
Growth Streak

Analyst Ratings

13 Buy
1 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 2.96
(+32.11% Upside)

Earnings

Latest Release
Feb 23, 2026
EPS / Forecast
0.02 / 5.40
Revenue / Forecast
393.48M / 249.71M
EPS Revisions
Last 90 days

FAQ

What were Integral Diagnostics Ltd's earnings for the latest quarter?

The Integral Diagnostics Ltd EPS (TTM) is 0.04. Integral Diagnostics Ltd reported sales of 393.48, net income of 8.96, and EPS of 0.02 for the latest quarter.

What was Integral Diagnostics Ltd's net income for the latest quarter?

Integral Diagnostics Ltd's net income for the latest quarter was 8.96.

How did Integral Diagnostics Ltd's performance compare year-over-year in the latest quarter?

The company's revenue moved from 374.34 million AUD in the previous quarter to 393.48 million AUD in the latest quarter, and net income moved from 5.07 million AUD to 8.96 million AUD compared to the previous quarter.

What is Integral Diagnostics Ltd's net profit margin on a TTM basis?

Integral Diagnostics Ltd's trailing twelve months (TTM) net profit margin is 1.83%.

How does Integral Diagnostics Ltd's debt to equity ratio compare to industry standards?

Integral Diagnostics Ltd's total debt-to-equity ratio is 88.22%.

What is Integral Diagnostics Ltd's return on investment on a TTM basis?

Integral Diagnostics Ltd's trailing twelve months (TTM) return on investment (ROI) is 2.06%.

How has Integral Diagnostics Ltd's total revenue grown this year?

Integral Diagnostics Ltd's total revenue was 374.34 million AUD in the previous quarter and 393.48 million AUD in the latest quarter.

What is Integral Diagnostics Ltd's gross margin on a TTM basis?

Integral Diagnostics Ltd's trailing twelve months (TTM) gross margin is 31.50%%.

What was Integral Diagnostics Ltd's revenue per share for the latest quarter?

Integral Diagnostics Ltd's revenue per share for the latest quarter was 39.17.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.